Beharry, Z.; Zemskova, M.; Mahajan, S.; Zhang, F.; Ma, J.; Xia, Z.; et al. (2009). Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells. Mol Cancer Ther; 8: 1473-83.
Browne, BC.; Crown, J.; Venkatesan, N.; Duffy, MJ.; Clynes, M.; Slamon, D.; et al. (2011). Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cells. Ann Oncol; 22: 68-73.
Iorio, M.V.; et al. (2006). MicroRNA gene expression deregulation in human breast cancer. Cancer Res; 65, 7065-7070 (2005). Nature Rev. Cancer; 6: 857-866,
Joinpoint Regression Program, Version 3.5.2. Bethesda, MD.; (2011). Statistical Research and Applications Branch, National Cancer Institute.
Koboldt, DC.; Fulton, RS.; McLellan, MD.; Schmidt, H.; Kalicki-Veizer, J.; McMichael, JF.; et al. (2012). Comprehensive molecular portraits of human breast tumours. Nature.
Lapointe, J.; et al. (2004). Gene expression profiling identifies clinically relevant subtypes of prostat cancer. Proc. Natl Acad. Sci. USA 101, 811-816.
Mecham, BH.; Klus, GT.; Strovel, J.; Augustus, M.; Byrne, D.; Bozso, P.; et al. Sequence-matched probes.
Online publication date: 1-Aug-2012.
Olff, AC.; Hammond, ME.; Hayes, DF.; (2012). Re: Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria. J Natl Cancer Inst; 104: 957-958.
Pfaffl, M.W.; (2010). The ongoing evolution of qPCR. Methods; 50: 215-216.
Prat, A.; Parker, JS.; Karginova, O.; Fan, C.; Livasy, C.; Herschkowitz, JI.; et al. (2010). Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res.
Produce increased cross-plat-form consistency and more reproducible biological results in microarray-based gene expression measurements. (2004). Nucleic Acids Res; 32:e74.
Protective effects of liquiritin apioside on cigarette smoke-induced lung epithelial cell injury. Fundamental & Clinical Pharmacology 26: 10.1111/fcp. 2012. 26. issue-4, 473-483.
Rhodes, D.R.; et al. (2005). Mining for regulatory programs in the cancer transcriptome.Nature Genet; 37, 579-583.
Rothenberg, M.E.; et al. (2008). Human and Rat Hepatocytes Cultured on Ultra-Web and Ultra-Web Polyamine Synthetic Matrices show Enhanced Physiologic Activity When Compared to Collagen. Application Note - Corning Life Sciences Technical Monograph CLS-AN-094: Article can be downloaded from Technical Information/ Cell Culture / Culture Surfaces at www.corning.com / lifesciences.-See more at: http://www.sigmaaldrich.com/technical-documents/articles/biofiles/evolution-of-cell.html#sthash.U8TjewtR.dpuf
Sun, Y.; Niu, J.; Huang, J.; (2009). Neuroendocrine differentiation in prostate cancer. Am J Transl Res; 1: 148-162.
Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Mortality-All COD, Aggregated With State, Total US (1969-2009) . Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2012. Released September 2012; underlying mortality data provided by National Center for Health Statistics 2012.
Surveillance Research Program, National Cancer Institute. (2012). SEER*Stat Software, version 7.1.0. Bethesda, MD.
The Analysis of Small Molecule Metabolite Profiles in the Blood as a Biomarker of Lung Cancer, Peter Mazzone et al. (2014). Chest, doi: 10.1378/chest.1989452, published online October.
Wang, W.; Epstein, JI.; (2008). Small cell carcinoma of the prostate: A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol; 32: 65-71.
Wang, SP.; Wang, WL.; Chang, YL.; et al. (2009). p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol; 11: 694-704.
Weinstein, I.B.; Joe, A.K.; (2006). Mechanisms of disease: Oncogene addiction—a rationale for molecular targeting in cancer therapy. Nature Clinical Practice Oncology; 3: 448-457.
Ying, M.; Li, D.; Yang, L.; Wang, M.; Wang, N.; Chen, Y.; et al. (2010). Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma. J Cancer Res Clin Oncol.
)